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Does It Matter?*Steven F. Bolling, MDI n this issue of the Journal, Kammerlander et al.(1), from Austria, describe an observational studyof 539 patients with previous left-sided heart
valve surgery. The majority underwent aortic, not
mitral, valve procedures and were followed for a
mean of 53 months to assess the impact of tricuspid
regurgitation (TR) on their outcome. Signiﬁcant TR,
deﬁned as moderate or severe, was present in 17%
of these patients post-operatively. As opposed to pa-
tients who did not have or develop TR, those who
did presented an entirely different demographic;
they had more mitral and tricuspid surgery, a greater
likelihood of having symptomatic heart failure, worse
kidney function, a higher rate of atrial ﬁbrillation,
and poor right ventricular (RV) systolic function.
Overall Kaplan-Meier survival by univariate analysis
was signiﬁcantly worse (p < 0.001) in patients with
TR; 36% of patients with TR died as opposed to only
19% of patients without TR.SEE PAGE 2633However, by multivariable Cox analysis, only RV
function, age, left atrial size, diabetes, and redo sta-
tus were signiﬁcantly associated with mortality, not
TR. Tricuspid regurgitation, per se, was not an “in-
dependent” inﬂuence on late mortality. The authors
conclude that RV dysfunction, not TR, is associated
with worsened survival after left heart surgery. They
also surmise that surgery for late TR following left
heart surgery may not be beneﬁcial and comment that*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
From the Department of Cardiac Surgery, University of Michigan, Ann
Arbor, Michigan. Dr. Bolling has reported that he has no relationships
relevant to the contents of this paper to disclose.studies are needed to deﬁne who would beneﬁt from
late redo surgery for TR.
There are signiﬁcant limitations to this study. It
was a single-center observational study, with no data
on rehospitalization for heart failure and quality of
life. Additionally, echo data appear to be incomplete
as to the timing, appearance, and degree of TR, and
echo determination of “right ventricular dysfunction”
in the presence of signiﬁcant TR is clearly difﬁcult
to assess. Furthermore, right heart catheterization
and hemodynamic data were unavailable in these
patients. Additionally, those who developed TR
had very different underlying pathology (aortic vs.
mitral), implying differing left ventricular geometry,
size, etc. Finally, as with all statistical analyses,
uncountable variables may exert great inﬂuence.
Nevertheless, the authors concluded that TR is not
“independently associated with survival late after left
heart valve surgery” (1).
The ﬁnding that late TR may be independently
innocuous or noninﬂuential appears somewhat con-
tradictory to previous ﬁndings regarding TR. The
seminal paper by Nath et al. (2), published in JACC in
2004, showed that both moderate and severe TR, at
any time, increased mortality independent of pul-
monary pressures or of left or right ventricular size
and function. This study encompassed more than
5,200 patients followed for >5 years. Recently, re-
searchers at the University of Pennsylvania again
conﬁrmed the adverse impact of late TR (3). Their 12-
year follow-up study showed a 4-fold increase in late
mortality when patients were left with signiﬁcant TR
following mitral surgery.
The clinical approach to TR has been inﬂuenced by
numerous studies, notably from Dreyfus et al. (4).
They randomized 311 patients undergoing left-sided
mitral valve surgery to either tricuspid annuloplasty
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2644or no tricuspid annuloplasty based on a tricuspid valve
annular diameter greater than twice the normal size
(>70 mm) regardless of the grade of regurgitation. At 2
years following the surgery, return of signiﬁcant
“moderate-to-severe tricuspid regurgitation” was 2%
in those who had tricuspid annuloplasty versus almost
50% for those who did not. There was an adverse
mortality impact of late TR, which showed that despite
a good mitral result, TR does not go away or get better
over time. Other authors have reported that annulo-
plasty in the presence of tricuspid annular dilation can
stabilize TR grade, prevent an increase in RV size, and
favorably impact mortality (5–7). Conversely, Bernal
et al. (8) showed 35% 30-day mortality for redo iso-
lated tricuspid annuloplasty for late TR.
Additionally, the relationship between RVr func-
tion and TR is complex and intertwined. Yiu et al. (9)
showed in TR patients, who subsequently underwent
tricuspid valve annuloplasty during left heart valve
surgery, RV geometry, RV size, and TR were inde-
pendently associated with adverse events. Further-
more, Mukherjee and colleagues (10) demonstrated
experimentally that the RV gets better when isolated
RV is corrected. Recently, 2 large clinical reviews by
Desai et al. (11) and by Betrand et al. (12) conﬁrmed
this and showed that RV geometry and function
improve after tricuspid valve repair at the time of left-
sided valve surgery. These ﬁndings provided the ba-
sis of the Class IIa recommendation in the most recent
European Society of Cardiology/European Associa-
tion of CardioThoracic Surgeons (13) and AmericanCollege of Cardiology/American Heart Association
(14) guidelines suggesting tricuspid annuloplasty at
the time of left-sided surgery with any degree of TR or
“prophylactically” with tricuspid annular diameter
>40 mm.
So how does one interpret the conclusion, in this
observational study, that TR is not an independent
predictor of mortality? It may be that the interactions
among TR, the RV, pulmonary hypertension, and the
left ventricle is far too complex for this analysis.
Furthermore, physiological and demographic differ-
ences between the TR and no TR groups may have
been far too extensive to meaningfully “match” or
overcome in any mathematical or statistical way.
Although statistically following a multivariable Cox
analysis, TR was not “independently” shown to be a
predictor of mortality, logically we should not
conclude that late TR does not matter or has no in-
ﬂuence on outcome after left-sided heart surgery.
Signiﬁcant TR does not appear to be benign at any
time, and it probably does matter. Clearly a random-
ized, controlled trial of correction of TR/tricuspid
annular dilation may be needed to deﬁnitively
answer the question of whether TR is independently
associated with late mortality after left heart surgery.
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